Counterfeit medicines are unsafe and ineffective. The World Health Professions Alliance (WHPA) works to address the growing threat of counterfeit medicines to patient safety and public health. Included in their toolkit for healthcare professionals you will find: An overview of the situation on counterfeit medicines and the role of healthcare Read more…
In a 5 video series, Bayer documents the trail of fake medicines into Europe and the efforts of customs, the police and manufactures to stop these dangerous products from reaching the market. As part of INTERPOL’s Operation Pangea- an international control action to combat the smuggling of illegal medicines – in Read more…
Paul Newton of the Wellcome Trust explains why counterfeit medicines have dangerous ramifications even beyond death and disability. Watch the video here and click here to view more videos and resources about counterfeit medicines, a “Spotlight issue” of the Wellcome Trust. The Wellcome Trust is one of the world’s largest biomedical research Read more…
The World Health Organisation (WHO) outlines the following qualities of spurious/falsely-labelled/ falsified/counterfeit (SFFC) medical products: SFFC medicines are medicines that are deliberately and fraudulently mislabelled with respect to identity and/or source. Use of SFFC medicines can result in treatment failure or even death. Public confidence in health systems may be Read more…
This magazine is part of DHL’s Delivered Series. Check out Fight the Fakes on page 6.
The Institute of Medicine has published a report, Countering the Problem of Falsified and Substandard Drugs, to disclose its findings on the potential threats fake medicines have to consumers. The report highlights the heavy burden falsified medicines place upon developing countries, but notes that developed countries also experience incidents of Read more…
